Esperion Therapeutics Inc (ESPR)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -27.729 | -63.852 | -95.807 | -54.298 | -50.572 | -73.242 | -74.233 | -92.234 |
Return on Equity (%) | -29.069 | -70.564 | -124.648 | -196.158 | 376.853 | 183.643 | 89.744 | 53.738 |
Return on Invested Capital (%) | -37.296 | -91.344 | -163.572 | -188.416 | -235.302 | -479.502 | 683.254 | 120.93 |
Operating Margin (%) | N/A | N/A | N/A | -60.018 | -53.124 | -283.956 | -234.315 | -129.173 |
Net Profit Margin (%) | N/A | N/A | N/A | -65.491 | -63.086 | -343.044 | -309.585 | -179.868 |
Book Value Per Share | 10.133 | 9.3 | 2.947 | 0.723 | -3.446 | -3.133 | -4.343 | -4.002 |
Earnings Per Share | -3.324 | -6.348 | -7.523 | -3.534 | -5.143 | -4.28 | -3.133 | -1.84 |
Cash Per Share | 1.692 | 1.31 | 1.378 | 6.042 | 10.927 | 3.322 | 1.673 | 0.723 |
Working Capital Per Share | 8.778 | 6.492 | 2.919 | 5.296 | 9.023 | 4.066 | 2.07 | 0.394 |
Operating Profit Per Share | N/A | N/A | N/A | 5.395 | 8.067 | 1.031 | 0.657 | 0.644 |
EBIT Per Share | -3.324 | -6.348 | -7.523 | -3.534 | -5.143 | -4.28 | -3.133 | -1.84 |
EBITDA Per Share | -3.324 | -6.348 | -7.523 | -3.534 | -5.143 | -4.28 | -3.133 | -1.84 |
Free Cash Flow Per Share | -3.331 | -6.357 | -7.527 | -3.51 | -4.684 | -4.29 | -3.14 | -1.842 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 22,56M | 26,31M | 26,83M | 27,5M | 27,91M | 62,87M | 74,57M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 74,57M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -194.55 | N/A | N/A | N/A | 54.486 | N/A | N/A |
Net Profit Margin (%) | N/A | -253.685 | N/A | N/A | N/A | 44.304 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 372,4M |
Ratio cours/bénéfice | -1,78 |
Ratio prix/ventes | 3,2 |
Ratio prix/liquidités | 4,53 |
Ratio prix/valeur comptable | -0,82 |
Rendement de dividende | - |
Actions en circulation | 197,04M |
Volume moyen (1 semaine) | 4,23M |
Volume moyen (1 mois) | 4,88M |
Variation sur 52 semaines | -14,18% |
Plus haut sur 52 semaines | 3,94 |
Plus bas sur 52 semaines | 1,58 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales